U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520708) titled 'Performance and Safety of HyalganBio(R) Intra-Articular Injections as Add-On to Physical Exercise for Symptomatic Glenohumeral Osteoarthritis' on April 03.
Brief Summary: This investigation evaluates performance and safety of three intra-articular injections of HyalganBio(R), combined with a Physical Exercise Program (PEP) in subjects with glenohumeral osteoarthritis. The main goal is to see whether patients improve shoulder function six months after the first injection, compared with patients who only follow the exercise program. Improvement is measured using the Constant-Murley Score (CMS).
Participants first attend a screening ...